Atherosclerosis risk factors in children of parents with the metabolic syndrome

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages

  Akinci, Gulcin ^a   Coskun, Senol ^a   Akinci, Baris ^b   Hekimsoy, Zeliha ^a   Bayindir, Petek ^a   Onur, Ece ^a   Ozmen, Bilgin ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Family; Inflammation; Soluble CD40 ligand

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DIET RESTRICTION; ECHOCARDIOGRAPHY; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; MULTIPLE REGRESSION; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIODIAGNOSIS; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASODILATATION; WAIST HIP RATIO;

ADOLESCENT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CD40 LIGAND; CHILD; FEMALE; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; PARENTS; RISK FACTORS; STATISTICS AS TOPIC; VASODILATION;

EID: 34848857889     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.12.008     Document Type: Article

References (35)

1. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
2. Balkau B., Charles M.A., Drivsholm T., et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diab Metab 28 (2002) 364-376
3. Poulsen P., Vaag A., Kyvik K., and Beck-Nielsen H. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia 44 (2001) 537-543
4. Freeman M.S., Mansfield M.W., Barrett J.H., and Grant P.J. Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med 19 (2002) 994-999
5. Lee K.E., Klein B.E., and Klein R. Familial aggregation of components of the multiple metabolic syndrome in the framingham heart and offspring cohorts: genetic analysis workshop problem 1. BMC Genet 4 Suppl. 1 (2003) S94
6. Willeit J., Kiechl S., Oberhollenzer F., et al. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol 20 (2000) 529-537
7. Simon A., Segond P., Giard A.M., et al. Early diagnosis of silent atherosclerosis and detection of cardiovascular risk factors. A new strategy for the approach of cardiovascular prevention. Presse Med 22 (1993) 1033-1038
8. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 314 (1986) 488-500
9. Bassuk S.S., Rifai N., and Ridker P.M. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 29 (2004) 439-493
10. Park H.S., Park J.Y., and Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69 (2005) 29-35
11. Retnakaran R., Hanley A.J., Connelly P.W., et al. Elevated C-reactive protein in Native Canadian children: an ominous early complication of childhood obesity. Diab Obes Metab 8 (2006) 483-491
12. Balla J., Magyar M.T., Bereczki D., et al. Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease. Dis Markers 22 (2006) 133-140
13. Tanne D., Haim M., Goldbourt U., et al. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease. Int J Cardiol 107 (2006) 322-326
14. Danese S., and Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Crit Rev Immunol 25 (2005) 103-121
15. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
16. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
17. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 13 (2005) 322-327
18. McGee D.L. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 15 (2005) 87-97
19. Smoak C.G., Burke G.L., Webber L.S., et al. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol 125 (1987) 364-372
20. Flint A.J., and Rimm E.B. Commentary: obesity and cardiovascular disease risk among the young and old-is BMI the wrong benchmark?. Int J Epidemiol 35 (2006) 187-189
21. Liberopoulos E.N., Mikhailidis D.P., and Elisaf M.S. Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 6 (2005) 283-296
22. Ells L.J., Campbell K., Lidstone J., et al. Prevention of childhood obesity. Best Pract Res Clin Endocrinol Metab 19 (2005) 441-454
23. Raitakari O.T., Juonala M., Kahonen M., et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the cardiovascular risk in Young Finns Study. JAMA 290 (2003) 2277-2283
24. Gillman M.W., Rifas-Shiman S.L., Frazier A.L., et al. Family dinner and diet quality among older children and adolescents. Arch Fam Med 9 (2000) 235-240
25. Coon K.A., Goldberg J., Rogers B.L., and Tucker K.L. Relationships between use of television during meals and children's food consumption patterns. Pediatrics 107 (2001) E7
26. Birch L.L., and Fisher J.O. Development of eating behaviors among children and adolescents. Pediatrics 101 (1998) 539-549
27. Contento I.R., Basch C., Shea S., et al. Relationship of mothers' food choice criteria to food intake of preschool children: identification of family subgroups. Health Educ Q 20 (1993) 243-259
28. Birch L.L., Birch D., Marlin D.W., and Kramer L. Effects of instrumental consumption on children's food preference. Appetite 3 (1982) 125-134
29. Rutter M.K., Meigs J.B., Sullivan L.M., et al. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 (2004) 380-385
30. Ford E.S., Galuska D.A., Gillespie C., et al. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr 138 (2001) 486-492
31. Lobbes M.B., Lutgens E., Heeneman S., et al. Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis 187 (2006) 18-25
32. Schonbeck U., Varo N., Libby P., et al. Soluble CD40L and cardiovascular risk in women. Circulation 104 (2001) 2266-2268
33. Kinlay S., Schwartz G.G., Olsson A.G., et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation 110 (2004) 386-391
34. Stewart M.W., Humphriss D.B., Berrish T.S., et al. Features of syndrome X in first-degree relatives of NIDDM patients. Diab Care 18 (1995) 1020-1022
35. Liese A.D., Mayer-Davis E.J., Tyroler H.A., et al. Familial components of the multiple metabolic syndrome: the ARIC study. Diabetologia 40 (1997) 963-970